Key facts
- Highridge Medical’s last known valuation is $375.0M (Apr 2024).
- Notable investors include H.I.G. Capital, Concord Health Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Highridge Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Highridge Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Highridge Medical
Operator of a medical device manufacturing firm intended to develop and manufacture innovative spinal implant solutions for various surgical approaches. The company's portfolio offers a comprehensive range of spinal implant solutions across different categories, including motion preservation, minimally invasive surgery (MIS), bone healing, and core spine technologies, enabling surgeons to select the most appropriate treatment option for their patients, potentially leading to improved surgical outcomes.
- Sector
- Healthcare
- HQ
- Westminster, CO, United States
- Founded
- 2024
- Employees
- 500
- Website
- highridgemedical.com/
- Ownership
- Privately Held (backing)
Highridge Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Highridge Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Highridge Medical in its N-PORT filings yet. We sweep new filings monthly.